Fresenius SE & Co KGaA
XETRA:FRE

Watchlist Manager
Fresenius SE & Co KGaA Logo
Fresenius SE & Co KGaA
XETRA:FRE
Watchlist
Price: 48.595 EUR 1.09%
Market Cap: €27.4B

Operating Margin

9.8%
Current
Improving
by 2.2%
vs 3-y average of 7.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.8%
=
Operating Income
€2.2B
/
Revenue
€22.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.8%
=
Operating Income
€2.2B
/
Revenue
€22.3B

Peer Comparison

Country Company Market Cap Operating
Margin
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.4B EUR
Loading...
US
CVS Health Corp
NYSE:CVS
105.6B USD
Loading...
US
Cigna Group
XMUN:CGN
63B EUR
Loading...
US
Cigna Corp
NYSE:CI
74.7B USD
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.9B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.1B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.2B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.5B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...
US
DaVita Inc
NYSE:DVA
7.6B USD
Loading...

Market Distribution

In line with most companies in Germany
Percentile
70th
Based on 3 747 companies
70th percentile
9.8%
Low
-61 459.6% — 0.7%
Typical Range
0.7% — 9.8%
High
9.8% — 94 540%
Distribution Statistics
Germany
Min -61 459.6%
30th Percentile 0.7%
Median 4.5%
70th Percentile 9.8%
Max 94 540%

Fresenius SE & Co KGaA
Glance View

Fresenius SE & Co. KGaA, a titan in the global healthcare sector, traces its origins to a humble pharmacy in Frankfurt, Germany, in 1912. Since then, the company has evolved into a multifaceted healthcare conglomerate, positioning itself prominently in four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. Each segment synergizes to form a comprehensive healthcare ecosystem. Fresenius Medical Care, the crown jewel of the group, stands as the world’s leading provider of products and services for individuals with renal diseases. This division, with a focus on dialyzing patients suffering from chronic kidney failure, operates a vast network of dialysis clinics and manufactures dialysis machines and related products that account for a significant portion of its income. Meanwhile, Fresenius Kabi, the pharmaceutical and medical device division, specializes in lifesaving drugs and technologies for critically and chronically ill patients. This division thrives on providing clinical nutrition, infusion therapy, and generics, positioning itself as a critical player in hospitals worldwide. Fresenius Helios is acknowledged as Europe's largest private hospital operator, managing a vast array of healthcare facilities that deliver inpatient and outpatient care, ensuring a steady stream of revenue through diverse healthcare services. Lastly, Fresenius Vamed provides a wide range of services for healthcare facilities, from project development and construction to full operational management, allowing the company to gain financial benefits from turnkey hospital solutions and infrastructure development. Through these concerted efforts, Fresenius SE & Co. KGaA cements its role as a key stakeholder in the global healthcare market, generating substantial revenues while addressing diverse medical needs across the globe.

FRE Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
9.8%
=
Operating Income
€2.2B
/
Revenue
€22.3B
What is Fresenius SE & Co KGaA's current Operating Margin?

The current Operating Margin for Fresenius SE & Co KGaA is 9.8%, which is above its 3-year median of 7.6%.

How has Operating Margin changed over time?

Over the last 3 years, Fresenius SE & Co KGaA’s Operating Margin has increased from 9.4% to 9.8%. During this period, it reached a low of 5.7% on Jun 30, 2024 and a high of 9.9% on Jun 30, 2025.

Back to Top